Neumora Therapeutics, Inc. Contracts & Agreements
38 Contracts & Agreements
- Business Finance (4 contracts)
- Business Operations (2)
- Human Resources (19)
- Intellectual Property (9)
- Mergers & Acquisitions (2)
- Uncategorized (2)
- Second Amendment to License Agreement, dated May 17, 2024, by and between the Registrant and Vanderbilt University (Filed With SEC on August 6, 2024)
- Non-Employee Director Compensation Program (Filed With SEC on May 7, 2024)
- RBNC Therapeutics, Inc. Milestone Carveout Plan (Filed With SEC on May 7, 2024)
- Executive Employment Agreement, dated as of November 13, 2023, by and between the Registrant and Jason Duncan (Filed With SEC on March 7, 2024)
- Executive Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Carol Y. Suh (Filed With SEC on March 7, 2024)
- Form of Underwriting Agreement (Filed With SEC on September 11, 2023)
- Form of Common Stock Certificate (Filed With SEC on September 11, 2023)
- First Amendment to Exclusive License Agreement for GCase, dated June 14, 2022, by and between the Registrant and Amgen, Inc (Filed With SEC on September 11, 2023)
- Form of Indemnification and Advancement Agreement for directors and officers (Filed With SEC on September 11, 2023)
- Non-Employee Director Compensation Program (Filed With SEC on September 11, 2023)
- Employment Agreement by and between the Registrant and Joshua Pinto, Ph.D (Filed With SEC on August 25, 2023)
- Non-Employee Director Compensation Program (Filed With SEC on August 25, 2023)
- License Agreement, dated February 10, 2022, by and between the Registrant and Vanderbilt University (Filed With SEC on August 25, 2023)
- First Amendment to License Agreement, dated July 17, 2023, by and between the Registrant and Vanderbilt University (Filed With SEC on August 25, 2023)
- Form of Executive Employment Agreement (Filed With SEC on August 25, 2023)
- Form of Executive Employment Agreement for Chief Executive Officer (Filed With SEC on August 25, 2023)
- Separation Agreement by and between the Registrant and John Dunlop, Ph.D (Filed With SEC on August 25, 2023)
- Consulting Agreement, dated as of May 20, 2023, by and between the Registrant and John Dunlop, Ph.D (Filed With SEC on August 25, 2023)
- Executive Chairman Agreement, dated as of July 3, 2023, by and between the Registrant and Paul L. Berns (Filed With SEC on August 25, 2023)
- Executive Employment Agreement, dated as of June 2, 2023, by and between the Registrant and Henry O. Gosebruch (Filed With SEC on August 25, 2023)
- Agreement and Plan of Merger, dated June 1, 2020, by and among the Registrant, Berries Merger Sub, Inc, BlackThorn Therapeutics, Inc. and Fortis Advisors LLC (Filed With SEC on August 25, 2023)
- Agreement and Plan of Merger, dated November 24, 2020, by and among the Registrant, Alairion Merger Sub I, Inc, Alairion Merger Sub II, LLC, Alairion, Inc. and John F. Lee (Filed With SEC on August 25, 2023)
- Investors Rights Agreement, dated September 22, 2022, by and among the Registrant and the investors listed therein (Filed With SEC on August 25, 2023)
- Research Collaboration and License Agreement, dated September 10, 2021, by and between the Registrant and Amgen Inc (Filed With SEC on August 25, 2023)
- Exclusive License Agreement for CK1d, dated September 10, 2021, by and between the Registrant and Amgen Inc (Filed With SEC on August 25, 2023)
- Exclusive License Agreement for GCase, dated September 10, 2021, by and between the Registrant and Amgen Inc (Filed With SEC on August 25, 2023)
- License Agreement, dated November 23, 2015, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute (Filed With SEC on August 25, 2023)
- First Amendment to License Agreement, dated November 13, 2017, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute (Filed With SEC on August 25, 2023)
- Second Amendment to License Agreement, dated April 9, 2019, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute (Filed With SEC on August 25, 2023)
- 2020 Equity Incentive Plan (Filed With SEC on August 25, 2023)
- Form of Stock Option Agreement under the 2020 Equity Incentive Plan (Filed With SEC on August 25, 2023)
- Form of Restricted Stock Purchase Agreement under the 2020 Equity Incentive Plan (Filed With SEC on August 25, 2023)
- 2023 Incentive Award Plan (Filed With SEC on August 25, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2023 Incentive Award Plan (Filed With SEC on August 25, 2023)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2023 Incentive Award Plan (Filed With SEC on August 25, 2023)
- Employee Stock Purchase Plan (Filed With SEC on August 25, 2023)
- Employment Agreement by and between the Registrant and Paul L. Berns (Filed With SEC on August 25, 2023)
- Employment Agreement by and between the Registrant and John Dunlop, Ph.D (Filed With SEC on August 25, 2023)
